Research Detail
| 2024/09/05 / Erste Group Research |
Health Care sector with attractive risk/reward profile Rating changes: Novartis, Royal Bank of Canada, Pfizer, Alimentation Couche-Tard, Cadence Design Systems, Intel The prospects for a medium-term rise in the global stock market index are intact. Corporate sales will rise by around +3.5% this year. The consensus estimate for earnings growth in 2024 is an increase of +6.4%. Next year, earnings growth will rise to +12.6%. The expected P/E ratio 2024 of the global equity market index is 19.8x and the global dividend yield is 1.9%. The valuation is reasonable given the positive growth prospects. Profit growth in the most important countries in the emerging markets varies greatly. The forecast earnings growth of Indian companies is +10.1% (y/y) for 2024 and +13% (y/y) for 2025. The global recommendation list includes India's ICICI Bank as an attractive long-term buy recommendation. The earnings growth of Indian companies is higher than that of Chinese companies. Earnings growth of +7.9% (y/y) is forecast for these companies for 2024 and +7.5% (y/y) for 2025. Novartis: High profit growth of +20% y/y in 2Q24, positive outlook for 2H24 Royal Bank of Canada: 2Q24: Net interest income up 16% y/y, adjusted ROE at 16.4% Intel: Quality problems and high debt, negative risk/reward profile |
 Download PDF (8.7MB)
|
General information
| Author | Erste Group Research |
| Date | 2024/09/05 |
| Language |  |
| Product name | Recommendation List |
| Topic in focus | Equities |
| Economy in focus | Germany, Japan, United Kingdom, United States |
| Currency in focus | British Pound, Euro, US Dollar |
| Sector in focus | Automobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities |
| Download |
Related financial instruments
Page 1 of 5
| Name | ISIN | # Erste Group products |
| Walt Disney | US2546871060 | 0 |
| Walmart | US9311421039 | 0 |
| Volkswagen | DE0007664039 | 4 |
| Visa | US92826C8394 | 0 |
| Vinci | FR0000125486 | 0 |
| Vertex Pharmaceuticals | US92532F1003 | 0 |
| Verizon | US92343V1044 | 0 |
| Vale | BRVALEACNOR0 | 0 |
| UnitedHealth Group | US91324P1021 | 0 |
| Unilever | GB00B10RZP78 | 0 |
| UniCredit | IT0005239360 | 0 |
| UBS | CH0244767585 | 0 |
| Toyota Motor | JP3633400001 | 0 |
| TotalEnergies | FR0000120271 | 0 |
| Tokyo Electron | JP3571400005 | 0 |
| Thermo Fisher Scientific | US8835561023 | 0 |
| Tesla | US88160R1014 | 0 |
| Tencent | KYG875721634 | 0 |
| Taiwan Semiconductor | TW0002330008 | 0 |
| T-Mobile US | US8725901040 | 0 |
| Starbucks | US8552441094 | 0 |
| Southern Co | US8425871071 | 0 |
| Siemens | DE0007236101 | 0 |
| Shell | GB00B03MLX29 | 0 |
| ServiceNow | US81762P1021 | 0 |